Linezolid-resistant Staphylococcus cohnii, Greece

Emerging Infectious Diseases

Volumn 15, Issue 1, 2009, Pages 116-118

  Petinaki, Efi ^a,c   Kanellopoulou, Maria ^b   Damani, Anthi ^c   Foka, Antigoni ^d   Spiliopoulou, Iris ^d   Skalmoutsou, Nikoletta ^b   Raitsiou, Bogdan ^b   Valakis, Konstantinos ^b   Papafragas, Evangelos ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

^c INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BACTERIAL RNA; BETA LACTAM; BETA LACTAM ANTIBIOTIC; BIOLOGICAL MARKER; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINEZOLID; MACROLIDE; METICILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; RNA 23S; STREPTOGRAMIN; TEICOPLANIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CFR GENE; CLONAL VARIATION; CONTROLLED STUDY; DISEASE TRANSMISSION; DISK DIFFUSION; ENTEROCOCCUS FAECIUM; EPIDEMIC; EPSILOMETER TEST; EQUIPMENT; ERM GENE; FEMALE; GENETIC RESISTANCE; GREECE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; LETTER; MALE; MECA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS INFECTION; VAT GENE; VGA GENE;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; GREECE; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 58849119017     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1501.080769     Document Type: Letter

References (10)

1. Jones RN, Fritsche TR, Sader HS, Ross JE. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn Microbiol Infect Dis. 2007;59:309-17. DOI: 10.1016/j.diagmicrobio.2007.06.004
2. Pratti A, Karanika M, Maniatis AN, Petinaki E, Spiliopoulou I, Kolonitsiou F, et al. Activity of linezolid against gram-positive cocci: a multicentre study in Greek hospitals. Int J Antimicrob Agents. 2007;29:604-5. DOI: 10.1016/j.ijantimicag.2006.12.005
3. Kontos F, Petinaki E, Spiliopoulou I, Maniati M, Maniatis AN. Evaluation of a novel method based on PCR restriction fragment length polymorphism analysis of the tuf gene for the identification of Staphylococcus species. J Microbiol Methods. 2003;55:465-9. DOI: 10.1016/S0167-7012(03)00173-8
4. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI approved standard M100-S16. Wayne (PA): The Institute; 2005.
5. Lina G, Quaglia A, Reverdy ME, Leclercq R, Vandenesch F, Etienne J. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob Agents Chemother. 1999;43:1062-6.
6. Schmitz FJ, Fluit AC, Gondolf M, Beyrau R, Lindenlauf E, Verhoef J, et al. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother. 1999;43:253-9. DOI: 10.1093/jac/43.2.253
7. Pillai SK, Sakoulas G, Wennersten C, Eliopoulos GM, Moellering RC Jr, Ferraro MJ, et al. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis. 2002;186:1603-7. DOI: 10.1086/345368
8. Mendes RE, Deshpande LM, Castanheira M, DiPersio J, Saubolle MA, Jones RN. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother. 2008;52:2244-6. DOI: 10.1128/AAC.00231-08
9. Farrell DJ, Morrissey I, Bakker S, Buckridge S, Felmingham D. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob Agents Chemother. 2004;48:3169-71. DOI: 10.1128/AAC.48.8.3169-3171.2004
10. Kelly S, Collins J, Maguire M, Gowing C, Flanagan M, Donnelly M, et al. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother. 2008;61:901-7. DOI: 10.1093/jac/dkn043